Open Access

Pathogenic mechanism of miR-21 in autoimmune lymphoid hyperplasia syndrome

  • Authors:
    • Yonglong Yan
    • Xinna Deng
    • Xiaoran Ning
    • Fang Li
    • Jingjing Cao
  • View Affiliations

  • Published online on: April 13, 2017     https://doi.org/10.3892/ol.2017.6039
  • Pages: 4734-4740
  • Copyright: © Yan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

miR-21 plays an important role in immune responses and inflammatory diseases, but the mechanism of action of miR‑21 in autoimmune lymphoid hyperplasia syndrome still remains unclear. The aim of the present study was to assess the mechanism of miR‑21 in autoimmune disease, particularly, the autoimmune lymphoid hyperplasia syndrome. The pathology and immunity‑related phenotypes of miR‑21 transgenic mice, and the lymphocyte subsets were analyzed. The related T cell subsets and germinal center B (GCB) cells generated at the germinal center were detected with flow cytometry. The target genes of miR‑21 were evaluated with the luciferase reporter gene method. The homeostatic proliferation of the lymphocytes was detected with the EdU incorporation assay. Inflammatory infiltration occurred to the lung and liver of the transgenic mice at 8 weeks. The frequency of the regulatory helper T cells decreased slightly. Significantly increased double negative T cells were observed in the spleen of the transgenic mice (P<0.05). The immunoglobulins IgG1, IgG2a, IgG2b, and IgG3 in the serum of the transgenic mice aged 8 weeks were significantly higher than those in the wild-type mice aged 8 weeks (P<0.05). The percentages of the GCB cells in the peripheral lymphoid organs such as lymph nodes, mesenteric lymph nodes, PP and spleen in the transgenic mice aged 8‑52 weeks increased significantly (P<0.05). The percentage (26.32%) of the newly‑formed GCB cells derived from transgenic mice was significantly higher than that (3.87%) of the GCB cells derived from the wild-type mice. miR‑21 played a role of negative feedback regulation by inhibiting the NF‑κB signal pathway. The highly‑expressed miR‑21 B cells promoted homeostatic proliferation of the T cells. miR‑21 can promote homeostatic proliferation of lymphocytes by inhibiting the NF-κB signal pathway.

Introduction

Several studies have demonstrated that miR-21 has different expression profiles in various hematopoietic cells (1). Low levels of miR-21 were reported in naive T cells, while in regulatory helper T cells (Treg) this level was reported as high (2). High expression of miR-21 also occurs in memory and effector T cells, and miR-21 expression is significantly upregulated after being stimulated by the T cell receptor (TCR) (3). High levels of miR-21 have been observed in Th1 cells, but miR-21 expression in Th2 cells is stronger. Low levels of miR-21 expression have been reported in precursor B cells and progenitor B cells but germinal center B (GCB) has been shown to express high levels of miR-21 (4). miR-21 can serve as a negative feedback control factor in innate immunity (5).

In the human mononuclear cell line, when LPS stimulates THP-1 cells miR-21 expression is quickly upregulated via the toll-like receptor (6). Prior reports showed that LPS, IL-1α and TNF-α can induce miR-21 expression via NF-κB (7). NF-κB activation increases the expression of miR-21, while miR-21 reduces the NF-κB activity by downregulating TRAF6 and IRAKl (8,9). The negative feedback mechanism of miR-21 plays an important role in physiological and pathological processes in innate immunity, virus infection and tumorigenesis. miR-21 also plays an indispensable role in acquired immunity. In activated T cells, miR-21 inhibits cell death induced by activation of T lymphocytes and inhibits production of IL-2 (10). miR-21 also plays an important role in peripheral immune tolerance of Treg (11), and miR-21 has been found to be implicated in autoimmune diseases such as rheumatoid arthritis (RA) (11,12). In joint synovial tissue of RA patients, the level of miR-21 has been reported to be significantly higher compared to synovial tissue in osteoarthritis patients. Additionally, it was reported that in vitro stimulation of joint synovial cell cultures obtained from RA patients with TNF-α and IL-1α, increased miR-21 expression level (13). Autoimmune lymphoproliferative syndrome (ALPS) also known as Canale-Smith syndrome is caused by excess hyperplasia of lymphocytes due to apoptosis disorders (14). ALPS is a rare disease caused by lymphocyte proliferation due to programmed death of lymphocytes or apoptosis disorders (15).

To better study the pathological and physiological significance of miR-21, we investigated the biological functions of miR-21 in ALPS and revealed a mechanism different from inflammation negative feedback. It provides a new explanation for pathogenesis of ALPS.

Materials and methods

Experimental animals

Healthy SPF male C57b6/L mice aged 6–8 weeks (Laboratory Animal Center, Hebei Medical University, Shijiazhuang, China; laboratory animal license no. SCXK 2015-0004) and miR-21 gene knockout mice (Jakson Laboratory, CA, USA; laboratory animal no. 016856), weighing 20–25 g were used in the present study. Mice were divided into two groups: i) The wild-type group (WT) and ii) the transgenic group (TG). Approval for the animal experiments was received from the Animal Ethics Committee of Hebei Province General Hospital.

Experimental methods
RT-polymerase chain reaction (PCR)

Heart, liver, lung, kidney, spleen, and lymph node tissues were extracted from mice in both groups. TRIzol (1 ml) was added to 5 mg of each sample and after mixing, samples were left for 5 min at room temperature. Chloroform was added (1/5 volume) to the sample and mixed well for 1 min and left at room temperature for 5 min. Sample was then centrifuged for 15 min at 10,000 × g at room temperature.

Equal volume of isopropanol was then added and mixed gently by turning the tube upside down. After 10 min at room temperature, sample was centrifuged for 10 min at 10,000 × g at 4°C. Supernatant was discarded and 1 ml of 75% ethyl alcohol was added to the pellet. Appropriate amount of DEPC was dissolved in water and precipitated. The reaction system was 25 µl including fluorescence RT-PCR reaction liquid (20 µl), DNA polymerase-I (1 µl), reverse transcriptase (0.35 µl), and template RNA (5 µl). They were mixed and centrifuged for 10 sec at 5,000 × g.

Real-time fluorescence RT-PCR amplification process was as follows: Reverse transcription for 30 min at 50°C; pre-denatured for 3 min at 95°C; denatured at 95°C for 15 sec, annealed for 30 sec at 50°C, extended for 30 min at 72°C, 5 cycles in total; denatured for 10 sec at 95°C; annealed for 40 sec at 55°C, 45 cycles in total.

H&E staining and immune histologic chemical staining

Paraffin sections of the heart, liver, lung, kidney, spleen, and lymph node tissues were routinely dewaxed. Sections were incubated with 3% H2O2 methanol solution for 10 min at room temperature to block the endogenous peroxidase. Sections were rinsed 3 times with PBS, repaired for 8 min at high temperature using 0.01 mol/l citrate buffer solution (pH 6.0), cooled to the room temperature, and rinsed with PBS 3 times (5 min each). Some sections were stained using H&E and the remaining sections were blocked for 30 min at 37°C after dropwise addition of goat serum operating fluid. After dropwise addition of PNA (1:200) (Sigma-Aldrich, St. Louis, MO, USA), they were allowed to stand overnight at 4°C and rinsed with PBS 3 times (5 min each). After dropwise addition of biotinylated goat anti-rabbit second antibody operating solution (cat no. P0203; Boster Inc., Wuhan, China), sections were incubated for 20 min at 37°C and rinsed with PBS 3 times (5 min each). After addition of horseradish peroxidase-marked streptavidin operating liquid, the sections were incubated for 20 min at 37°C and rinsed with PBS 3 times (5 min each). Sections were then developed with DAB, re-stained with hematoxylin and differentiated with 0.1% hydrochloric ethanol. Samples were then immersed in tap water, dehydrated, clarified, and mounted with neutral resin.

Analysis of serum immunoglobulin (IgG) concentrations and types

MILLIPLEX MAP Mouse IgG Isotyping Magnetic Bead Panel, MGAMMAG-300K (both from Biosharp, Hefei, China) were used. We used IgG (1, 2a, 2b, and 3), IgM, and IgA (diluted at 1:25,000) following the protocol reported by Ruan et al (16).

Flow cytometry

Mice were sacrificed and spleen, lymph node, mesenteric lymph nodes, PP globule, and thymus gland were extracted and placed in pre-cooled cell culture media. Two mouse thigh bones were taken and both ends were cut out. A 1 ml syringe was used to draw 5% FBS buffer solution (Gibco-BRL, Grand Island, NY, USA) and the red marrow was flushed twice. In order to prepare single-cell suspension, red blood cell lysis buffer was added to spleen and bone marrow to remove red blood cells. Cell counts were performed and cell concentration was adjusted to 1×106/100 µl. Index antibody was then added and transferred to ice-bath and incubated for ≥45 min away from light. Mouse monoclonal antibodies, such as anti-CD95/Fas (dilution, 1:100; cat. no. 15A7), anti-CD38 (dilution, 1:100; cat. no. 90), anti-CD3 (dilution, 1:100; cat. no. 17A2), anti-CD4 (dilution, 1:100; cat. no. RM4 5), anti-CD4 (dilution, 1:100; cat. no. GK1.5), anti-CD44 (dilution, 1:100; cat. no. IM7), anti-CD62L (dilution, 1:100; cat. no. MEL 14), anti-CD25 (dilution, 1:100; cat. no. PC61.5), anti-CD69 (dilution, 1:100; cat. no. H1.2F3) and anti-B220/CD45R (dilution, 1:100; cat. no. RA3 6B2) were all purchased from eBioscience (San Diego, CA, USA). FlowJo (Tree Star, Inc., Ashland, OR, USA) was used for data analysis.

Adoptive transfer

The flow cytometer FACSAria II (BD Biosciences) was used to sort out the non-GCB cells. The resulting cells were washed once with cell culture medium and stabilized for 1–2 h in a culture flask for subsequent experiments. Non-GCB cells (1×106) and CD4+ T cells (1×106) were mixed (1:1). Cell suspension was injected into the immunodeficiency SCID mice via the caudal vein without any spillage (17). The percentage of the newly-generated GCB cells from the donor and the expression of Fas in the newly-generated GCB cells were measured at 7 days after adoptive transfer.

Homeostatic proliferation test

Click-iT® EdU cell proliferation assay was used. A 200 µl EdU (500 µg/ml; KeyGene Biotech, Nanjing, China) was injected peritoneally at 24 days after adoptive transfer and strengthened every 48 h and mice were sacrificed at day 7. To complete the test, we followed the instructions provided by the kit's manufacturer (18). The surface marker was B220 or CD4 and cells were routinely stained, incubated, fixed, and permeated. The Click-iTrM EdU test solution was then added and flow cytometer was used to analyze the homeostatic proliferation of the lymphocytes.

Dual-luciferase reporter gene reporting method

The Dual-Luciferase® Reporter Assay kit (KeyGene Biotech) was used. The vector (pZZX-Luc-Fas) of Fas 3′-non-translated region (3′-UTR), miR-146a (pEZX-miR-146), and non-significant control miR-scramble (pEZX-miR-scramble) were extracted and purified following the instructions provided by the kit's manufacturer (19).

Statistical analysis

We used SPSS 19.0 software (IBM, Armonk, NY, USA) for data analysis. Measurement data were presented as mean ± standard deviation. Dependent t-test was used for intergroup significance comparison. P<0.05 was considered to indicate a statistically significant difference.

Results

miR-21 gene knockout characteristics

miR-21 expression levels in various visceral organs were measured using quantitative PCR (Fig. 1A). In the TG, miR-21 expression levels in spleen and lymph node were significantly higher than those in the WT at 3 weeks after birth (Fig. 1B). The average lymph node volume in the TG was 3 times larger than that in the WT at 3 weeks after birth. The average volume was 8 times larger at 4 weeks after birth, and ~4 times larger at 6 weeks (Fig. 1C). In the TG, we detected inflammatory cell infiltration in lung and liver at 8 weeks after birth (Fig. 1D).

miR-21 gene knockout mice exhibiting characteristics of autoimmune lymphoid hyperplasia syndrome

Results obtained from immunophenotyping showed that in the TG, the number of T cells in thymus gland was at normal level (Fig. 2A-C). However, the number of various cell subsets increased significantly (Fig. 2D), while the number of other cell types, such as Treg cells decreased slightly (Fig. 2E). Results revealed that the levels CD25, CD69, CD44 and CD62L were at normal levels (Fig. 2F).

In the TG, the percentage of double negative T cells (DNT) in the spleen increased significantly. CD3+CD4CD8 TCRaIB+ served as the surface markers and we detected the frequency and absolute quantity of the DNT cells in the spleen at 8, 26 and 52 weeks. It was found that in the transgenic mice, DNT cells were accumulated in the spleen (Fig. 2G and H).

miR-21 gene knockout mice spontaneously collect the germinal center B cells and increasing IgG in serum

The levels of IgGl, IgG2b, IgG2a, and IgG3 in the serum of 8-week old transgenic mice were 3–6 times higher than those in the wild-type mice. IgGl and IgG2a serum levels in 52-week old transgenic mice were still higher compared with the wild-type mice, however IgG2b and IgG3 levels were normal in 52-week old transgenic mice (Fig. 3A and B).

In miR-21 transgenic mice, spontaneous germinal center reaction was detected in peripheral lymphoid organs (Fig. 3C), and the proportion of B cells in the germinal center in the miR-146 transgenic mice was significantly higher than that in the wild-type mice (Fig. 3D and E). Similar results were observed in the mesenteric lymph nodes, PP globules, and spleen (Fig. 3F and G).

miR-21 downregulates the Fas protein expression in GCB cells

Fas protein expression in various subsets of the lymphocytes including CD3+CD4+ T cells, CD3+CD8+ T cells, CD3+CD4+CD8 cells, TCRaIB+DNT cells, B220+PNA+CD38low non-GCB cells, B220+PNA and CD38high GCB cells were evaluated in the transgenic mice, using flow cytometry. High Fas protein expression was only detected in the GCB cell subsets in wild-type mice (Fig. 4A). miR-21 overexpression effectively reduced Fas protein expression in GCB cells. Compared to wild-type mice, the Fas average fluorescence intensity in the GCB cells in the transgenic mice decreased by more than 50% (Fig. 4B). Our results demonstrated that Fas was the direct target of miR-21 (Fig. 4C).

miR-21 strengthens homeostatic proliferation of lymphocytes

Natural B cells or CD4+ T cells from transgenic and wild-type mice were transferred into the SCID recipient mice with immunodeficiency. Homeostatic proliferation of lymphocytes was studied (EdU incorporation assay). Seven days after adoptive transfer, the proliferation level of the natural B cells originating from the transgenic mice was significantly higher than those B cells originating from the wild-type mice. However, no significant difference was observed in the case of CD4+ T cells (Fig. 5).

Discussion

It has been shown that miR-21, miR-132, and miR-155 levels are upregulated when the THP cells are stimulated by LPS. Other reports demonstrated that miR-21 was a NF-κB-dependent natural immune negative feedback regulatory factor (20), and the major target genes were shown to be TRAF6 and IRAK-1/2 (21). It has been reported that, miR-21 gene knockout mice usually suffer from spontaneous autoimmune disorders and die before reaching maturity. Following characteristics were observed in these mice: i) Spleen and lymph node enlargement, ii) inflammatory infiltration in multiple organs, and iii) imbalance in peripheral immune tolerance of T cells. Moreover, myeloid cell proliferation and peripheral lymphoid organs tumors might occur in these mice.

T cell survival, activation and apoptosis rate in transgenic mice with overexpressed miR-21 were not different compared with wild-type mice. It seems that miR-21 regulates the T cell mediated immune response via a negative feedback mechanism. TCR transfers the antigen-activated signals to T cells and the three signal pathways implicated in this induction are: NFAT, AP-1 and NF-κB (22). Imbalance of NF-κB in T cells may lead to immuno-inflammatory responses mediated by T cells and malignant tumor genesis (23). We detected a large number of DNT cells in the spleen. This observation along with other observations such as enlargement of lymph nodes and spleens and presence of inflammatory cell infiltration in liver and lung were in line with the characteristics of human autoimmune lymphoid hyperplasia syndrome (ALPS).

Although spontaneous ALPS occurred in miR-21 transgenic mice, the majority of ALPS patients may be affected by non-malignant enlargement of lymph nodes and spleen at a tender age. In these cases, the number of DNT cells increased significantly and IgG level in the serum was considerably elevated (24).

Spleen and lymph gland enlargement is often observed in 3-week old miR-21 transgenic mice and a peak is usually reached at 4 weeks after birth. In all young transgenic mice, we observed an increase in the number of DNT cells in the spleen, while IgGl, IgG2b, IgG2a, and IgG3 levels in 8-week old transgenic mice were higher than those in wild-type mice. These conditions were relieved at 52 weeks. miR-21 transgenic mice had an extremely high morbidity of pulmonary and hepatic inflammatory cell infiltration. Clinically, 4–5% of the ALPS patients have infiltrative pulmonary lesions and liver dysfunctions.

Genetic defects in typical ALPS patients mainly occur in the apoptosis pathway. These defects directly break the lymphocytes homeostasis and immune tolerance (25). Prior reports have shown that Fas gene mutation and Fas protein downregulation are the major causes for ALPS onset (26). Here, we demonstrated that miR-21 overexpression can downregulate the Fas expression in the GCB cells and finally lead to ALPS in transgenic mice. However, in transgenic mice, Fas dysfunction occurs in B cells with highly-expressed miR-21.

In our transgenic mice, a decrease in Fas expression on the surface of the natural B cells allowed an easy transformation into GCB cells. It seems that Fas downregulation in GCB cells may disturb lymphocyte homeostasis and excessive lymphoid hyperplasia. Furthermore, Fas downregulation in GCB cells can promote the survival of mature T cells. Usually, activated T cells lose their CD4 or CD8 co-receptors, therefore an accumulation in DNT cells may occur. These observations supported the idea that miR-21 is involved in ALPS pathogenesis and may provide a new explanation of ALPS pathogenesis, particularly in cases with viral infection and chronic inflammation. We believe that the miR-21 deficient mice experienced an autoimmune disease similar to ALPS.

References

1 

Halász T, Horváth G, Pár G, Werling K, Kiss A, Schaff Z and Lendvai G: miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan. World J Gastroenterol. 21:7814–7823. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Croci S, Zerbini A, Boiardi L, Muratore F, Bisagni A, Nicoli D, Farnetti E, Pazzola G, Cimino L, Moramarco A, et al: MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis. Ann Rheum Dis. 20:78462015.

3 

Punga AR, Andersson M, Alimohammadi M and Punga T: Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients. J Neurol Sci. 356:90–96. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Wu XN, Ye YX, Niu JW, Li Y, Li X, You X, Chen H, Zhao LD, Zeng XF, Zhang FC, et al: Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus. Sci Transl Med. 6:246ra99. 2014. View Article : Google Scholar

5 

Quinn SR and O'Neill LA: The role of microRNAs in the control and mechanism of action of IL-10. Curr Top Microbiol Immunol. 380:145–155. 2014.PubMed/NCBI

6 

Ma X, Zhou J, Zhong Y, Jiang L, Mu P, Li Y, Singh N, Nagarkatti M and Nagarkatti P: Expression, regulation and function of microRNAs in multiple sclerosis. Int J Med Sci. 11:810–818. 2014. View Article : Google Scholar : PubMed/NCBI

7 

Tang ZM, Fang M, Wang JP, Cai PC, Wang P and Hu LH: Clinical relevance of plasma miR-21 in new-onset systemic lupus erythematosus patients. J Clin Lab Anal. 28:446–451. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Haider BA, Baras AS, McCall MN, Hertel JA, Cornish TC and Halushka MK: A critical evaluation of microRNA biomarkers in non-neoplastic disease. PLoS One. 9:e895652014. View Article : Google Scholar : PubMed/NCBI

9 

Smigielska-Czepiel K, van den Berg A, Jellema P, van der Lei RJ, Bijzet J, Kluiver J, Boots AM, Brouwer E and Kroesen BJ: Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs. Genes Immun. 15:115–125. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Chafin CB, Regna NL, Hammond SE and Reilly CM: Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment. Int Immunopharmacol. 17:894–906. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Bao H, Hu S, Zhang C, Shi S, Qin W, Zeng C, Zen K and Liu Z: Inhibition of miRNA-21 prevents fibrogenic activation in podocytes and tubular cells in IgA nephropathy. Biochem Biophys Res Commun. 444:455–460. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Wang H, Peng W, Ouyang X, Li W and Dai Y: Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res. 160:198–206. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Mycko MP, Cichalewska M, Machlanska A, Cwiklinska H, Mariasiewicz M and Selmaj KW: MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination. Proc Natl Acad Sci USA. 109:pp. E1248–E1257. 2012; View Article : Google Scholar : PubMed/NCBI

14 

Stagakis E, Bertsias G, Verginis P, Nakou M, Hatziapostolou M, Kritikos H, Iliopoulos D and Boumpas DT: Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis. 70:1496–1506. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, Li J, Zhou H, Tang Y and Shen N: MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol. 184:6773–6781. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Ruan Q, Wang T, Kameswaran V, Wei Q, Johnson DS, Matschinsky F, Shi W and Chen YH: The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc Natl Acad Sci USA. 108:pp. 12030–12035. 2011; View Article : Google Scholar : PubMed/NCBI

17 

Bostjancic E and Glavac D: Importance of microRNAs in skin morphogenesis and diseases. Acta Dermatovenerol Alp Pannonica Adriat. 17:95–102. 2008.PubMed/NCBI

18 

Alisi A, Da Sacco L, Bruscalupi G, Piemonte F, Panera N, de Vito R, Leoni S, Bottazzo GF, Masotti A and Nobili V: Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab Invest. 91:283–293. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Dey N, Das F, Mariappan MM, Mandal CC, Ghosh-Choudhury N, Kasinath BS and Choudhury GG: MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes. J Biol Chem. 286:25586–25603. 2011. View Article : Google Scholar : PubMed/NCBI

20 

Bergman P, James T, Kular L, Ruhrmann S, Kramarova T, Kvist A, Supic G, Gillett A, Pivarcsi A and Jagodic M: Next-generation sequencing identifies microRNAs that associate with pathogenic autoimmune neuroinflammation in rats. J Immunol. 190:4066–4075. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Fognani E, Giannini C, Piluso A, Gragnani L, Monti M, Caini P, Ranieri J, Urraro T, Triboli E, Laffi G, et al: Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia. PLoS One. 8:e629652013. View Article : Google Scholar : PubMed/NCBI

22 

Xu WD, Pan HF, Li JH and Ye DQ: MicroRNA-21 with therapeutic potential in autoimmune diseases. Expert Opin Ther Targets. 17:659–665. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Koelsch KA, Webb R, Jeffries M, Dozmorov MG, Frank MB, Guthridge JM, James JA, Wren JD and Sawalha AH: Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse. J Autoimmun. 41:168–174. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Kimura J, Ichii O, Miyazono K, Nakamura T, Horino T, Otsuka-Kanazawa S and Kon Y: Overexpression of Toll-like receptor 8 correlates with the progression of podocyte injury in murine autoimmune glomerulonephritis. Sci Rep. 4:72902014. View Article : Google Scholar : PubMed/NCBI

25 

Dong L, Wang X, Tan J, Li H, Qian W, Chen J, Chen Q, Wang J, Xu W, Tao C, et al: Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis. J Cell Mol Med. 18:2213–2224. 2014. View Article : Google Scholar : PubMed/NCBI

26 

van der Geest KS, Smigielska-Czepiel K, Park JA, Abdulahad WH, Kim HW, Kroesen BJ, van den Berg A, Boots AM, Lee EB and Brouwer E: SF Treg cells transcribing high levels of Bcl-2 and microRNA-21 demonstrate limited apoptosis in RA. Rheumatology (Oxford). 54:950–958. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June-2017
Volume 13 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yan Y, Deng X, Ning X, Li F and Cao J: Pathogenic mechanism of miR-21 in autoimmune lymphoid hyperplasia syndrome. Oncol Lett 13: 4734-4740, 2017
APA
Yan, Y., Deng, X., Ning, X., Li, F., & Cao, J. (2017). Pathogenic mechanism of miR-21 in autoimmune lymphoid hyperplasia syndrome. Oncology Letters, 13, 4734-4740. https://doi.org/10.3892/ol.2017.6039
MLA
Yan, Y., Deng, X., Ning, X., Li, F., Cao, J."Pathogenic mechanism of miR-21 in autoimmune lymphoid hyperplasia syndrome". Oncology Letters 13.6 (2017): 4734-4740.
Chicago
Yan, Y., Deng, X., Ning, X., Li, F., Cao, J."Pathogenic mechanism of miR-21 in autoimmune lymphoid hyperplasia syndrome". Oncology Letters 13, no. 6 (2017): 4734-4740. https://doi.org/10.3892/ol.2017.6039